Get ready to mark your calendars because the much anticipated third quarter financial results of Vanda Pharmaceuticals (NASDAQ: VNDA) are set to be unveiled on Wednesday 6th November 2024. Investors and market watchers will have the chance to dive into the company's financial performance as the announcement is scheduled after market close.
The latest projections from financial analysts on Wall Street suggest that the organization is likely to reveal an estimated $0.16 loss per share for the quarter. Additionally, the company is expected to announce revenueS of $49.15 million for the period.
In the corresponding quarter of the previous year, the company's earnings report unveiled total revenue reached an impressive $38.82 million during that specific period.
Financial experts on Wall Street have shared their predictions regarding the company's annual performance, estimating a total revenue of $198.33 million. Additionally, they are expecting the company to report loss of $0.49 per share for the full year 2024.
In addition, The firm will review the third quarter financial results on 6th November 2024 at 04:30 PM eastern time, in a conference call with public.
Vanda Pharmaceuticals (VNDA) experienced a trading range of $4.62 to $4.71, along with a total volume of 360.80 thousand shares during the day. The stock concluded Friday's regular trading session at $4.66, demonstrating an increase of 0.22 percent.
